Please login to the form below

Not currently logged in
Email:
Password:

neurodegenerative diseases

This page shows the latest neurodegenerative diseases news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk to buy Dicerna Pharmaceuticals for $3.3bn

Novo Nordisk to buy Dicerna Pharmaceuticals for $3.3bn

Dicerna believes its proprietary GalXC and GalXC-Plus RNAi technologies will lead to the development of RNAi-based therapies to treat both rare and more prevalent diseases. ... Collectively, they have more than 20 active discovery, preclinical or

Latest news

More from news
Approximately 3 fully matching, plus 65 partially matching documents found.

Latest Intelligence

  • Piloting a route to the biosimilars opportunities in Europe Piloting a route to the biosimilars opportunities in Europe

    Biological medicines represent a major advance in the treatment of serious pathological conditions such as cancer,  neurodegenerative and autoimmune diseases, in the form of biosimilars. ... For orphan designations (medicine for rare diseases),

  • Alzheimer’s disease: the search for a cure Alzheimer’s disease: the search for a cure

    Advances in technology are providing huge opportunities to intervene decades earlier, when these diseases first start to take hold. ... That’s where the Early Detection of Neurodegenerative diseases (EDoN) initiative comes in.

  • The search for treatments for Parkinson’s disease The search for treatments for Parkinson’s disease

    and a decade as senior director of neurodegenerative diseases research at Merck Serono where he served as its leader for in vitro pharmacology in neurology, including in multiple sclerosis, Parkinson’s ... and Alzheimer’s diseases.

  • Alzheimer’s: the search for a cure Alzheimer’s: the search for a cure

    big diseases in the field, such as Alzheimer’s, is too limited to make near-term success likely. ... Based on what we felt was the state of the art in terms of understanding the pathogenesis of major diseases, especially neurodegenerative diseases, and

  • A roadmap to the successful treatment of Alzheimer’s disease A roadmap to the successful treatment of Alzheimer’s disease

    Nevertheless, strategies for developing successful therapeutic interventions are shifting. We have developed a five-point roadmap to successful treatments for Alzheimer’s disease and neurodegenerative diseases. ... Hyper-stimulation of microglial cells

More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...